Epithelial-mesenchymal transition in human cancer: Comprehensive reprogramming of metabolism, epigenetics, and differentiation

Pharmacology and Therapeutics

Volumn 150, Issue , 2015, Pages 33-46

  Li, Linna ^a   Li, Wenliang ^b,c,d  

^a BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^b Brown Foundation Institute of Molecular Medicine   (United States)

^c Division of Oncology   (United States)

^d UNIVERSITY OF TEXAS   (United States)

Author keywords

Cancer stem cells; Differentiation; Epigenetics; Epithelial mesenchymal transition; Metabolism

Indexed keywords

ANTINEOPLASTIC AGENT;

CELL DIFFERENTIATION; DRUG EFFECTS; EPITHELIAL MESENCHYMAL TRANSITION; GENETIC EPIGENESIS; GENETICS; GLYCOLYSIS; HUMAN; METABOLISM; NEOPLASMS; PATHOLOGY;

ANTINEOPLASTIC AGENTS; CELL DIFFERENTIATION; EPIGENESIS, GENETIC; EPITHELIAL-MESENCHYMAL TRANSITION; GLYCOLYSIS; HUMANS; NEOPLASMS;

EID: 84939981489     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2015.01.004     Document Type: Review

References (177)

1. M. Agathocleous, and W.A. Harris Metabolism in physiological cell proliferation and differentiation Trends Cell Biol 23 2013 484 492
2. A. Aljada, and S.A. Mousa Metformin and neoplasia: implications and indications Pharmacol Ther 133 2012 108 115
3. D. Anastasiou, G. Poulogiannis, J.M. Asara, M.B. Boxer, J.K. Jiang, and M. Shen Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses Science 334 2011 1278 1283
4. B.P. Ashburner, S.D. Westerheide, and A.S. Baldwin Jr. The p65 (RelA) subunit of NFkappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression Mol Cell Biol 21 2001 7065 7077
5. A. Barrallo-Gimeno, and M.A. Nieto The Snail genes as inducers of cell movement and survival: implications in development and cancer Development 132 2005 3151 3161
6. B.E. Bernstein, T.S. Mikkelsen, X. Xie, M. Kamal, D.J. Huebert, and J. Cuff A bivalent chromatin structure marks key developmental genes in embryonic stem cells Cell 125 2006 315 326
7. D. Bonnet, and J.E. Dick Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell Nat Med 3 1997 730 737
8. A.L. Bracha, A. Ramanathan, S. Huang, D.E. Ingber, and S.L. Schreiber Carbon metabolism-mediated myogenic differentiation Nat Chem Biol 6 2010 202 204
9. V. Byles, L. Zhu, J.D. Lovaas, L.K. Chmilewski, J. Wang, and D.V. Faller SIRT1 induces EMT by cooperating with EMT transcription factors and enhances prostate cancer cell migration and metastasis Oncogene 31 2012 4619 4629
10. L. Cai, B.M. Sutter, B. Li, and B.P. Tu Acetyl-CoA induces cell growth and proliferation by promoting the acetylation of histones at growth genes Mol Cell 42 2011 426 437
11. R.A. Cairns, I.S. Harris, and T.W. Mak Regulation of cancer cell metabolism Nat Rev Cancer 11 2011 85 95
12. E.E. Cameron, K.E. Bachman, S. Myöhänen, J.G. Herman, and S.B. Baylin Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer Nat Genet 21 1999 103 107
13. E.P. Candido, R. Reeves, and J.R. Davie Sodium butyrate inhibits histone deacetylation in cultured cells Cell 14 1978 105 113
14. P. Ceppi, G. Mudduluru, R. Kumarswamy, I. Rapa, G.V. Scagliotti, and M. Papotti Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer Mol Cancer Res 8 2010 1207 1216
15. C.L. Chaffer, I. Brueckmann, C. Scheel, A.J. Kaestli, P.A. Wiggins, and L.O. Rodrigues Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state Proc Natl Acad Sci U S A 108 2011 7950 7955
16. C.L. Chaffer, N.D. Marjanovic, T. Lee, G. Bell, C.G. Kleer, and F. Reinhardt Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity Cell 154 2013 61 74
17. A. Chiarugi, C. Dölle, R. Felici, and M. Ziegler The NAD metabolome - a key determinant of cancer cell biology Nat Rev Cancer 12 2012 741 752
18. C.R. Chong, and B.A. Chabner Mysterious metformin Oncologist 14 2009 1178 1181
19. C.C. Chou, K.H. Lee, I.L. Lai, D. Wang, X. Mo, and S.K. Kulp AMPK reverses the mesenchymal phenotype of cancer cells by targeting the Akt-MDM2-Foxo3a signaling axis Cancer Res 74 2014 4783 4795
20. S. Chung, P.P. Dzeja, R.S. Faustino, C. Perez-Terzic, A. Behfar, and A. Terzic Mitochondrial oxidative metabolism is required for the cardiac differentiation of stem cells Nat Clin Pract Cardiovasc Med 4 2007 S60 S67
21. M.A. Cichon, and D.C. Radisky ROS-induced epithelial-mesenchymal transition in mammary epithelial cells is mediated by NF-kB-dependent activation of Snail Oncotarget 5 2014 2827 2838
22. H.G. Crabtree Observations on the carbohydrate metabolism of tumours Biochem J 23 1929 536 545
23. F. Crea, E.M. Hurt, L.A. Mathews, S.M. Cabarcas, L. Sun, and V.E. Marquez Pharmacologic disruption of Polycomb Repressive Complex 2 inhibits tumorigenicity and tumor progression in prostate cancer Mol Cancer 10 2011 40
24. E. Cuyàs, B. Corominas-Faja, and J.A. Menendez The nutritional phenome of EMT-induced cancer stem-like cells Oncotarget 5 2014 3970 3982
25. L. Dang, D.W. White, S. Gross, B.D. Bennett, M.A. Bittinger, and E.M. Driggers Cancer-associated IDH1 mutations produce 2 hydroxyglutarate Nature 462 2009 739 744
26. M. Daskalakis, T.T. Nguyen, C. Nguyen, P. Guldberg, G. Köhler, and P. Wijermans Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2′-deoxycytidine (decitabine) treatment Blood 100 2002 2957 2964
27. P. Di Fazio, R. Schneider-Stock, D. Neureiter, K. Okamoto, T. Wissniowski, and S. Gahr The pan-deacetylase inhibitor panobinostat inhibits growth of hepatocellular carcinoma models by alternative pathways of apoptosis Cell Oncol 32 2010 285 300
28. C. Dong, T. Yuan, Y. Wu, Y. Wang, T.W. Fan, and S. Miriyala Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer Cancer Cell 23 2013 316 331
29. P.P. Dzeja, S. Chung, R.S. Faustino, A. Behfar, and A. Terzic Developmental enhancement of adenylate kinase-AMPK metabolic signaling axis supports stem cell cardiac differentiation PLoS ONE 6 2011 e19300
30. G. Eades, Y. Yao, M. Yang, Y. Zhang, S. Chumsri, and Q. Zhou miR-200a regulates SIRT1 expression and epithelial to mesenchymal transition (EMT)-like transformation in mammary epithelial cells J Biol Chem 286 2011 25992 26002
31. R.L. Elstrom, D.E. Bauer, M. Buzzai, R. Karnauskas, M.H. Harris, and D.R. Plas Akt stimulates aerobic glycolysis in cancer cells Cancer Res 64 2004 3892 3899
32. J.P. Etchegaray, L. Zhong, and R. Mostoslavsky The histone deacetylase SIRT6: at the crossroads between epigenetics, metabolism and disease Curr Top Med Chem 13 2013 2991 3000
33. T. Fiaschi, A. Marini, E. Giannoni, M.L. Taddei, P. Gandellini, and A. De Donatis Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay Cancer Res 72 2012 5130 5140
34. I.J. Fidler The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited Nat Rev Cancer 3 2003 453 458
35. M.E. Figueroa, O. Abdel-Wahab, C. Lu, P.S. Ward, J. Patel, and A. Shih Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation Cancer Cell 18 2010 553 567
36. C.D. Folmes, T.J. Nelson, A. Martinez-Fernandez, D.K. Arrell, J.Z. Lindor, and P.P. Dzeja Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming Cell Metab 14 2011 264 271
37. F. Fuks, W.A. Burgers, A. Brehm, L. Hughes-Davies, and T. Kouzarides DNA methyltransferase Dnmt1 associates with histone deacetylase activity Nat Genet 24 2000 88 91
38. P. Gao, I. Tchernyshyov, T.C. Chang, Y.S. Lee, K. Kita, and T. Ochi c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism Nature 458 2009 762 765
39. A. Gaspar-Maia, A. Alajem, E. Meshorer, and M. Ramalho-Santos Open chromatin in pluripotency and reprogramming Nat Rev Mol Cell Biol 12 2011 36 47
40. E. Giannoni, F. Bianchini, L. Calorini, and P. Chiarugi Cancer associated fibroblasts exploit reactive oxygen species through a proinflammatory signature leading to epithelial mesenchymal transition and stemness Antioxid Redox Signal 14 2011 2361 2371
41. E. Giannoni, F. Bianchini, L. Masieri, S. Serni, E. Torre, and I.L. Calorin Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness Cancer Res 70 2010 6945 6956
42. A.R. Grassian, F. Lin, R. Barrett, Y. Liu, W. Jiang, and M. Korpal Isocitrate dehydrogenase (IDH) mutations promote a reversible ZEB1/microRNA (miR)-200-dependent epithelial-mesenchymal transition (EMT) J Biol Chem 287 2012 42180 42194
43. C. Gregorian, J. Nakashima, J. Le Belle, J. Ohab, R. Kim, and A. Liu Pten deletion in adult neural stem/progenitor cells enhances constitutive neurogenesis J Neurosci 29 2009 1874 1886
44. D.A. Guertin, and D.M. Sabatini Defining the role of mTOR in cancer Cancer Cell 12 2007 9 22
45. N.P. Gunasinghe, A. Wells, E.W. Thompson, and H.J. Hugo Mesenchymal-epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer Cancer Metastasis Rev 31 2012 469 678
46. P.B. Gupta, C.M. Fillmore, G. Jiang, S.D. Shapira, K. Tao, and C. Kuperwasser Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells Cell 146 2011 633 644
47. P.B. Gupta, T.T. Onder, G. Jiang, K. Tao, C. Kuperwasser, and R.A. Weinberg Identification of selective inhibitors of cancer stem cells by high-throughput screening Cell 138 2009 645 659
48. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674
49. J. Hanai, N. Doro, A.T. Sasaki, S. Kobayashi, L.C. Cantley, and P. Seth Inhibition of lung cancer growth: ATP citrate lyase knockdown and statin treatment leads to dual blockade of mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3-kinase (PI3K)/AKT pathways J Cell Physiol 227 2012 1709 1720
50. J.A. Hanover, M.W. Krause, and D.C. Love Bittersweet memories: linking metabolism to epigenetics through O-GlcNAcylation Nat Rev Mol Cell Biol 13 2012 312 321
51. H. Harris A long view of fashions in cancer research Bioessays 27 2005 833 838
52. W.J. Harris, X. Huang, J.T. Lynch, G.J. Spencer, J.R. Hitchin, and Y. Li The histone demethylase KDM1A sustains the oncogenic potential of MLL-AF9 leukemia stem cells Cancer Cell 21 2012 473 487
53. G.W. Hart, M.P. Housley, and C. Slawson Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins Nature 446 2007 1017 1022
54. S. Hino, A. Sakamoto, K. Nagaoka, K. Anan, Y. Wang, and S. Mimasu FAD-dependent lysine-specific demethylase-1 regulates cellular energy expenditure Nat Commun 3 2012 758
55. R. Iglesias-Bartolome, V. Patel, A. Cotrim, K. Leelahavanichkul, A.A. Molinolo, and J.B. Mitchell mTOR inhibition prevents epithelial stem cell senescence and protects from radiation-induced mucositis Cell Stem Cell 11 2012 401 414
56. S. Imai, and L. Guarente Ten years of NAD-dependent SIR2 family deacetylases: implications for metabolic diseases Trends Pharmacol Sci 31 2010 212 220
57. S.E. Inzucchi, D.G. Maggs, G.R. Spollett, S.L. Page, F.S. Rife, and V. Walton Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus N Engl J Med 338 1998 867 872
58. S. Ito, A.C. D'Alessio, O.V. Taranova, K. Hong, L.C. Sowers, and Y. Zhang Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification Nature 466 2010 1129 1133
59. H. Jang, T.W. Kim, S. Yoon, S.Y. Choi, T.W. Kang, and S.Y. Kim O-GlcNAc regulates pluripotency and reprogramming by directly acting on core components of the pluripotency network Cell Stem Cell 11 2012 62 74
60. S. Javaid, J. Zhang, E. Anderssen, J.C. Black, B.S. Wittner, and K. Tajima Dynamic chromatin modification sustains epithelial-mesenchymal transition following inducible expression of Snail-1 Cell Rep 5 2013 1679 1689
61. H. Jiang, A. Shukla, X. Wang, W.Y. Chen, B.E. Bernstein, and R.G. Roeder Role for Dpy-30 in ES cell-fate specification by regulation of H3K4 methylation within bivalent domains Cell 144 2011 513 525
62. P.A. Jones, and S.B. Baylin The epigenomics of cancer Cell 128 2007 683 692
63. J.A. Joyce, and J.W. Pollard Microenvironmental regulation of metastasis Nat Rev Cancer 9 2009 239 252
64. W.G. Kaelin Jr. SDH5 mutations and familial paraganglioma: somewhere Warburg is smiling Cancer Cell 16 2009 180 182
65. W.G. Kaelin Jr., and S.L. McKnight Influence of metabolism on epigenetics and disease Cell 153 2013 56 69
66. R. Kalluri, and R.A. Weinberg The basics of epithelial-mesenchymal transition J Clin Invest 119 2009 1420 1428
67. J.G. Kang, S.Y. Park, S. Ji, I. Jang, S. Park, and H.S. Kim O-GlcNAc protein modification in cancer cells increases in response to glucose deprivation through glycogen degradation J Biol Chem 284 2009 34777 34784
68. S. Katada, A. Imhof, and P. Sassone-Corsi Connecting threads: epigenetics and metabolism Cell 148 2012 24 28
69. Y. Katoh, T. Ikura, Y. Hoshikawa, S. Tashiro, T. Ito, and M. Ohta Methionine adenosyltransferase II serves as a transcriptional corepressor of Maf oncoprotein Mol Cell 41 2011 554 566
70. Y. Khew-Goodall, and G.J. Goodall Myc-modulated miR-9 makes more metastases Nat Cell Biol 12 2010 209 211
71. T. Kiesslich, M. Pichler, and D. Neureiter Epigenetic control of epithelial-mesenchymal-transition in human cancer Mol Clin Oncol 1 2013 3 11
72. do Y. Kim, L.M. Davis, P.G. Sullivan, M. Maalouf, T.A. Simeone, and J. van Brederode Ketone bodies are protective against oxidative stress in neocortical neurons J Neurochem 101 2007 1316 1326
73. J.W. Kim, I. Tchernyshyov, G.L. Semenza, and C.V. Dang HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia Cell Metab 3 2006 177 185
74. A. King, M.A. Selak, and E. Gottlieb Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer Oncogene 25 2006 4675 4682
75. W.H. Koppenol, P.L. Bounds, and C.V. Dang Otto Warburg's contributions to current concepts of cancer metabolism Nat Rev Cancer 11 2011 325 337
76. S. Lamouille, E. Connolly, J.W. Smyth, R.J. Akhurst, and R. Derynck TGF-β-induced activation of mTOR complex 2 drives epithelial-mesenchymal transition and cell invasion J Cell Sci 125 2012 1259 1273
77. A.A. Lane, and B.A. Chabner Histone deacetylase inhibitors in cancer therapy J Clin Oncol 27 2009 5459 5468
78. E. Letouzé, C. Martinelli, C. Loriot, N. Burnichon, N. Abermil, and C. Ottolenghi SDH mutations establish a hypermethylator phenotype in paraganglioma Cancer Cell 23 2013 739 752
79. L. Li, C. Liu, J.T. Chang, G. Du, and W. Li CDKL2 promotes epithelial-mesenchymal transition and breast cancer progression Oncotarget 5 2014 10840 10853
80. B. Li, B. Qiu, D.S. Lee, Z.E. Walton, J.D. Ochocki, and L.K. Mathew Fructose-1,6-bisphosphatase opposes renal carcinoma progression Nature 513 2014 251 255
81. F. Li, Y. Wang, K.I. Zeller, J.J. Potter, D.R. Wonsey, and K.A. O'Donnell Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis Mol Cell Biol 25 2005 6225 6234
82. J. Li, and B.P. Zhou Activation of β-catenin and Akt pathways by Twist are critical for the maintenance of EMT associated cancer stem cell-like characters BMC Cancer 11 2011 49
83. S. Lim, A. Janzer, A. Becker, A. Zimmer, R. Schüle, and R. Buettner Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology Carcinogenesis 31 2010 512 520
84. T. Lin, A. Ponn, X. Hu, B.K. Law, and J. Lu Requirement of the histone demethylase LSD1 in Snai1-mediated transcriptional repression during epithelial-mesenchymal transition Oncogene 29 2010 4896 4904
85. S.F. Liu, S.Y. Chang, T.C. Lee, L.Y. Chuang, J.Y. Guh, and C.Y. Hung Dioscorea alata attenuates renal interstitial cellular fibrosis by regulating Smad- and epithelial-mesenchymal transition signaling pathways PLoS ONE 7 2012 e47482
86. J. Liu, L. Gao, H. Zhang, D. Wang, M. Wang, and J. Zhu Succinate dehydrogenase 5 (SDH5) regulates glycogen synthase kinase 3β-β-catenin-mediated lung cancer metastasis J Biol Chem 288 2013 29965 29973
87. P. Liu, and M.J. Wilson miR-520c and miR-373 upregulate MMP9 expression by targeting mTOR and SIRT1, and activate the Ras/Raf/MEK/Erk signaling pathway and NF-kB factor in human fibrosarcoma cells J Cell Physiol 227 2012 867 876
88. J.W. Locasale Serine, glycine and one-carbon units: cancer metabolism in full circle Nat Rev Cancer 13 2013 572 583
89. C. Lu, and C.B. Thompson Metabolic regulation of epigenetics Cell Metab 16 2012 9 17
90. Z. Luka, S.H. Mudd, and C. Wagner Glycine N-methyltransferase and regulation of S-adenosylmethionine levels J Biol Chem 284 2009 22507 22511
91. S.A. Mani, W. Guo, M.J. Liao, E.N. Eaton, A. Ayyanan, and A.Y. Zhou The epithelial-mesenchymal transition generates cells with properties of stem cells Cell 133 2008 704 715
92. R. Maruyama, S. Choudhury, A. Kowalczyk, M. Bessarabova, B. Beresford-Smith, and T. Conway Epigenetic regulation of cell type-specific expression patterns in the human mammary epithelium PLoS Genet 7 2011 e1001369
93. 2 regulates stem cells through Wnt/β-catenin signalling Nat Cell Biol 12 2010 1007 1013
94. M.T. McCabe, H.M. Ott, G. Ganji, S. Korenchuk, C. Thompson, and G.S. Van Aller EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations Nature 492 2012 108 112
95. E.L. McCoy, R. Iwanaga, P. Jedlicka, N.S. Abbey, L.A. Chodosh, and K.A. Heichman Six1 expands the mouse mammary epithelial stem/progenitor cell pool and induces mammary tumors that undergo epithelial-mesenchymal transition J Clin Invest 119 2009 2663 2677
96. O.G. McDonald, H. Wu, W. Timp, A. Doi, and A.P. Feinberg Genome-scale epigenetic reprogramming during epithelial-to-mesenchymal transition Nat Struct Mol Biol 18 2011 867 874
97. E. Metzger, M. Wissmann, N. Yin, J.M. Müller, R. Schneider, and A.H. Peters LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription Nature 437 2005 436 439
98. M.M. Mihaylova, and R.J. Shaw The AMPK signalling pathway coordinates cell growth, autophagy and metabolism Nat Cell Biol 13 2011 1016 1023
99. K. Moran-Crusio, L. Reavie, A. Shih, O. Abdel-Wahab, D. Ndiaye-Lobry, and C. Lobry Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation Cancer Cell 20 2011 11 24
100. A.P. Morel, M. Lièvre, C. Thomas, G. Hinkal, S. Ansieau, and A. Puisieux Generation of breast cancer stem cells through epithelial-mesenchymal transition PLoS ONE 3 2008 e2888
101. D.J. Mulholland, N. Kobayashi, M. Ruscetti, A. Zhi, L.M. Tran, and J. Huang Pten loss and RAS/MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem/progenitor cells Cancer Res 72 2012 1878 1889
102. D. Nakada, T.L. Saunders, and S.J. Morrison Lkb1 regulates cell cycle and energy metabolism in haematopoietic stem cells Nature 468 2010 653 658
103. M.A. Nieto The snail superfamily of zinc-finger transcription factors Nat Rev Mol Cell Biol 3 2002 155 166
104. J. Oleksyszyn Hyperglycemia and tumor energy metabolism J Pharmacol Biomed Anal 1 2012 1
105. D. Pan, C. Mao, and Y.X. Wang Suppression of gluconeogenic gene expression by LSD1-mediated histone demethylation PLoS ONE 8 2013 e66294
106. G. Pan, S. Tian, J. Nie, C. Yang, V. Ruotti, and H. Wei Whole-genome analysis of histone H3 lysine 4 and lysine 27 methylation in human embryonic stem cells Cell Stem Cell 1 2007 299 312
107. A.D. Panopoulos, O. Yanes, S. Ruiz, Y.S. Kida, D. Diep, and R. Tautenhahn The metabolome of induced pluripotent stem cells reveals metabolic changes occurring in somatic cell reprogramming Cell Res 22 2012 168 177
108. I. Papandreou, R.A. Cairns, L. Fontana, A.L. Lim, and N.C. Denko HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption Cell Metab 3 2006 187 197
109. S.Y. Park, H.S. Kim, N.H. Kim, S. Ji, S.Y. Cha, and J.G. Kang Snail1 is stabilized by O-GlcNAc modification in hyperglycaemic condition EMBO J 29 2010 3787 3796
110. J.M. Perry, X.C. He, R. Sugimura, J.C. Grindley, J.S. Haug, and S. Ding Cooperation between both Wnt/{beta}-catenin and PTEN/PI3K/Akt signaling promotes primitive hematopoietic stem cell self-renewal and expansion Genes Dev 25 2011 1928 1942
111. M.A. Pierotti, F. Berrino, M. Gariboldi, C. Melani, A. Mogavero, and T. Negri Targeting metabolism for cancer treatment and prevention: metformin, an old drug with multi-faceted effects Oncogene 32 2013 1475 1487
112. K. Polyak, and R.A. Weinberg Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits Nat Rev Cancer 9 2009 265 273
113. C. Quivoron, L. Couronné, V. Della Valle, C.K. Lopez, I. Plo, and O. Wagner-Ballon TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis Cancer Cell 20 2011 25 38
114. R.B. Robey, and N. Hay Is Akt the "Warburg kinase"? - Akt-energy metabolism interactions and oncogenesis Semin Cancer Biol 19 2009 25 31
115. D. Rohle, J. Popovici-Muller, N. Palaskas, S. Turcan, C. Grommes, and C. Campos An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells Science 340 2013 626 630
116. C.B. Rountree, S. Senadheera, J.M. Mato, G.M. Crooks, and S.C. Lu Expansion of liver cancer stem cells during aging in methionine adenosyltransferase 1A-deficient mice Hepatology 47 2008 1288 1297
117. B.C. Roy, T. Kohno, R. Iwakawa, T. Moriguchi, T. Kiyono, and K. Morishita Involvement of LKB1 in epithelial-mesenchymal transition (EMT) of human lung cancer cells Lung Cancer 70 2010 136 145
118. M. Sabbah, S. Emami, G. Redeuilh, S. Julien, G. Prévost, and A. Zimber Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers Drug Resist Updat 11 2008 123 151
119. M. Sasaki, C.B. Knobbe, J.C. Munger, E.F. Lind, D. Brenner, and A. Brüstle IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics Nature 488 2012 656 659
120. T. Schenk, W.C. Chen, S. Göllner, L. Howell, L. Jin, and K. Hebestreit Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia Nat Med 18 2012 605 611
121. M.S. Schieber, and N.S. Chandel ROS links glucose metabolism to breast cancer stem cell and EMT phenotype Cancer Cell 23 2013 265 267
122. M.A. Selak, S.M. Armour, E.D. MacKenzie, H. Boulahbel, D.G. Watson, and K.D. Mansfield Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase Cancer Cell 7 2005 77 85
123. J. Selhub, and J.W. Miller The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine Am J Clin Nutr 55 1992 131 138
124. G.L. Semenza HIF-1: upstream and downstream of cancer metabolism Curr Opin Genet Dev 20 2010 51 56
125. D.B. Shackelford, and R.J. Shaw The LKB1-AMPK pathway: metabolism and growth control in tumour suppression Nat Rev Cancer 9 2009 563 575
126. M.D. Shahbazian, and M. Grunstein Functions of site-specific histone acetylation and deacetylation Annu Rev Biochem 76 2007 75 100
127. S. Shaker, M. Bernstein, L.F. Momparler, and R.L. Momparler Preclinical evaluation of antineoplastic activity of inhibitors of DNA methylation (5-aza-2′-deoxycytidine) and histone deacetylation (trichostatin A, depsipeptide) in combination against myeloid leukemic cells Leuk Res 27 2003 437 444
128. S. Shankar, D. Kumar, and R.K. Srivastava Epigenetic modifications by dietary phytochemicals: implications for personalized nutrition Pharmacol Ther 138 2013 1 17
129. C. Shen, R. Beroukhim, S.E. Schumacher, J. Zhou, M. Chang, and S. Signoretti Genetic and functional studies implicate HIF1α as a 14q kidney cancer suppressor gene Cancer Discov 1 2011 222 235
130. L. Shi, R. Jackstadt, H. Siemens, H. Li, T. Kirchner, and H. Hermeking p53-induced miR-15a/16-1 and AP4 form a double-negative feedback loop to regulate epithelial-mesenchymal transition and metastasis in colorectal cancer Cancer Res 74 2014 532 542
131. Y. Shi, F. Lan, C. Matson, P. Mulligan, J.R. Whetstine, and P.A. Cole Histone demethylation mediated by the nuclear amine oxidase homolog LSD1 Cell 119 2004 941 953
132. T. Shimazu, M.D. Hirschey, J. Newman, W. He, K. Shirakawa, and N. Le Moan Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor Science 339 2013 211 214
133. B.Y. Shorning, D. Griffiths, and A.R. Clarke Lkb1 and Pten synergise to suppress mTOR-mediated tumorigenesis and epithelial-mesenchymal transition in the mouse bladder PLoS ONE 6 2011 e16209
134. N. Shyh-Chang, G.Q. Daley, and L.C. Cantley Stem cell metabolism in tissue development and aging Development 140 2013 2353 2547
135. N. Shyh-Chang, J.W. Locasale, C.A. Lyssiotis, Y. Zheng, R.Y. Teo, and S. Ratanasirintrawoot Influence of threonine metabolism on S-adenosylmethionine and histone methylation Science 339 2013 222 226
136. P. Simic, E.O. Williams, E.L. Bell, J.J. Gong, M. Bonkowski, and L. Guarente SIRT1 suppresses the epithelial-to-mesenchymal transition in cancer metastasis and organ fibrosis Cell Rep 3 2013 1175 1186
137. A.P. Smith, A. Verrecchia, G. Fagà, M. Doni, D. Perna, and F. Martinato A positive role for Myc in TGFbeta-induced Snail transcription and epithelial-to-mesenchymal transition Oncogene 28 2009 422 430
138. S. Stintzing, R. Kemmerling, T. Kiesslich, B. Alinger, M. Ocker, and D. Neureiter Myelodysplastic syndrome and histone deacetylase inhibitors: "to be or not to be acetylated"? J Biomed Biotechnol 2011 2011 214143
139. M.L. Suvà, N. Riggi, M. Janiszewska, I. Radovanovic, P. Provero, and J.C. Stehle EZH2 is essential for glioblastoma cancer stem cell maintenance Cancer Res 69 2009 9211 9218
140. K. Takubo, N. Goda, W. Yamada, H. Iriuchishima, E. Ikeda, and Y. Kubota Regulation of the HIF-1alpha level is essential for hematopoietic stem cells Cell Stem Cell 7 2010 391 402
141. W.L. Tam, and R.A. Weinberg The epigenetics of epithelial-mesenchymal plasticity in cancer Nat Med 19 2013 1438 1449
142. J.P. Thiery, H. Acloque, R.Y. Huang, and M.A. Nieto Epithelial-mesenchymal transitions in development and disease Cell 139 2009 871 890
143. K.V. Tormos, E. Anso, R.B. Hamanaka, J. Eisenbart, J. Joseph, and B. Kalyanaraman Mitochondrial complex III ROS regulate adipocyte differentiation Cell Metab 14 2011 537 544
144. M. Upadhyay, J. Samal, M. Kandpal, O.V. Singh, and P. Vivekanandan The Warburg effect: insights from the past decade Pharmacol Ther 137 2013 318 330
145. M.G. Vander Heiden, L.C. Cantley, and C.B. Thompson Understanding the Warburg effect: the metabolic requirements of cell proliferation Science 324 2009 1029 1033
146. J.E. Visvader, and G.J. Lindeman Cancer stem cells: current status and evolving complexities Cell Stem Cell 10 2012 717 728
147. L. Vrba, T.J. Jensen, J.C. Garbe, R.L. Heimark, A.E. Cress, and S. Dickinson Role for DNA methylation in the regulation of miR-200c and miR-141 expression in normal and cancer cells PLoS ONE 5 2010 e8697
148. J.J. Wallin, J. Guan, K.A. Edgar, W. Zhou, R. Francis, and A.C. Torres Active PI3K pathway causes an invasive phenotype which can be reversed or promoted by blocking the pathway at divergent nodes PLoS ONE 7 2012 e36402
149. J. Wang, P. Alexander, and S.L. McKnight Metabolic specialization of mouse embryonic stem cells Cold Spring Harb Symp Quant Biol 76 2011 183 193
150. J. Wang, P. Alexander, L. Wu, R. Hammer, O. Cleaver, and S.L. McKnight Dependence of mouse embryonic stem cells on threonine catabolism Science 325 2009 435 439
151. Z. Wang, S. Ali, S. Banerjee, B. Bao, Y. Li, and A.S. Azmi Activated K-Ras and INK4a/Arf deficiency promote aggressiveness of pancreatic cancer by induction of EMT consistent with cancer stem cell phenotype J Cell Physiol 228 2013 556 562
152. X. Wang, X. Pan, and J. Song AMP-activated protein kinase is required for induction of apoptosis and epithelial-to-mesenchymal transition Cell Signal 22 2010 1790 1797
153. H. Wang, H.S. Wang, B.H. Zhou, C.L. Li, F. Zhang, and X.F. Wang Epithelial-mesenchymal transition (EMT) induced by TNF-α requires AKT/GSK-3β-mediated stabilization of snail in colorectal cancer PLoS ONE 8 2013 e56664
154. Y. Wang, H. Zhang, Y. Chen, Y. Sun, F. Yang, and W. Yu LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer Cell 138 2009 660 672
155. O. Warburg On the origin of cancer cells Science 123 1956 309 314
156. P.S. Ward, J. Patel, D.R. Wise, O. Abdel-Wahab, B.D. Bennett, and H.A. Coller The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate Cancer Cell 17 2010 225 234
157. P.S. Ward, and C.B. Thompson Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate Cancer Cell 21 2012 297 308
158. K.E. Wellen, G. Hatzivassiliou, U.M. Sachdeva, T.V. Bui, J.R. Cross, and C.B. Thompson ATP-citrate lyase links cellular metabolism to histone acetylation Science 324 2009 1076 1080
159. K.K. Wong, J.A. Engelman, and L.C. Cantley Targeting the PI3K signaling pathway in cancer Curr Opin Genet Dev 20 2010 87 90
160. C.Y. Wu, Y.P. Tsai, M.Z. Wu, S.C. Teng, and K.J. Wu Epigenetic reprogramming and post-transcriptional regulation during the epithelial-mesenchymal transition Trends Genet 28 2012 454 463
161. M.Z. Wu, Y.P. Tsai, M.H. Yang, C.H. Huang, S.Y. Chang, and C.C. Chang Interplay between HDAC3 and WDR5 is essential for hypoxia-induced epithelial-mesenchymal transition Mol Cell 43 2011 811 822
162. Y. Xu, S.H. Lee, H.S. Kim, N.H. Kim, S. Piao, and S.H. Park Role of CK1 in GSK3beta-mediated phosphorylation and degradation of snail Oncogene 29 2010 3124 3133
163. C.S. Yang, C.G. Lopez, and T.M. Rana Discovery of nonsteroidal anti-inflammatory drug and anticancer drug enhancing reprogramming and induced pluripotent stem cell generation Stem Cells 29 2011 1528 1536
164. M. Yang, T. Soga, and P.J. Pollard Oncometabolites: linking altered metabolism with cancer J Clin Invest 123 2013 3652 3658
165. J. Yang, and R.A. Weinberg Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis Dev Cell 14 2008 818 829
166. M.H. Yang, and K.J. Wu TWIST activation by hypoxia inducible factor-1 (HIF-1): implications in metastasis and development Cell Cycle 7 2008 2090 2096
167. D. Yao, C. Dai, and S. Peng Mechanism of the mesenchymal-epithelial transition and its relationship with metastatic tumor formation Mol Cancer Res 9 2011 1608 1620
168. L. Yi, C. Lu, W. Hu, Y. Sun, and A.J. Levine Multiple roles of p53-related pathways in somatic cell reprogramming and stem cell differentiation Cancer Res 72 2012 5635 5645
169. H. Ying, A.C. Kimmelman, C.A. Lyssiotis, S. Hua, G.C. Chu, and E. Fletcher-Sananikone Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism Cell 149 2012 656 670
170. J.I. Yook, X.Y. Li, I. Ota, C. Hu, H.S. Kim, and N.H. Kim A Wnt-Axin2-GSK3beta cascade regulates Snail1 activity in breast cancer cells Nat Cell Biol 8 2006 1398 1406
171. Z. Yun, H.L. Maecker, R.S. Johnson, and A.J. Giaccia Inhibition of PPAR gamma 2 gene expression by the HIF-1-regulated gene DEC1/Stra13: a mechanism for regulation of adipogenesis by hypoxia Dev Cell 2 2002 331 341
172. J. Yun, C. Rago, I. Cheong, R. Pagliarini, P. Angenendt, and H. Rajagopalan Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells Science 325 2009 1555 1559
173. J. Zhang, and J. Liu Tumor stroma as targets for cancer therapy Pharmacol Ther 137 2013 200 215
174. X.D. Zhao, X. Han, J.L. Chew, J. Liu, K.P. Chiu, and A. Choo Whole-genome mapping of histone H3 Lys4 and 27 trimethylations reveals distinct genomic compartments in human embryonic stem cells Cell Stem Cell 1 2007 286 298
175. L. Zhong, A. D'Urso, D. Toiber, C. Sebastian, R.E. Henry, and D.D. Vadysirisack The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha Cell 140 2010 280 293
176. L. Zhou, H. Xue, P. Yuan, J. Ni, C. Yu, and Y. Huang Angiotensin AT1 receptor activation mediates high glucose-induced epithelial-mesenchymal transition in renal proximal tubular cells Clin Exp Pharmacol Physiol 37 2010 e152 e157
177. S. Zhu, W. Li, H. Zhou, W. Wei, R. Ambasudhan, and T. Lin Reprogramming of human primary somatic cells by OCT4 and chemical compounds Cell Stem Cell 7 2010 651 655